PRESS RELEASE published on 03/25/2025 at 07:30, 10 months 5 days ago CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency program CROSSJECT enhances collaboration with ETON PHARMACEUTICALS Inc. on ZENEO adrenal insufficiency program, introducing new hydrocortisone formulation for the hospital market Eton Pharmaceuticals Crossject Hydrocortisone Adrenal Insufficiency ZENEO
BRIEF published on 03/10/2025 at 14:22, 10 months 19 days ago Crossject : Mise à jour sur les droits de vote et actions au 31 janvier 2025 Droits De Vote Capital Social Actions Pharmaceutique Crossject
BRIEF published on 03/10/2025 at 14:22, 10 months 19 days ago Crossject: Update on voting rights and shares as of January 31, 2025 Share Capital Voting Rights Actions Pharmaceutical Crossject
PRESS RELEASE published on 03/10/2025 at 14:17, 10 months 19 days ago Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Crossject communique le nombre total de droits de vote et d’actions composant son capital social au 31 janvier 2025, conformément aux règlements de l’AMF et du Code de commerce Droits De Vote Capital Social Pharmaceutique Communiqué Crossject
BRIEF published on 02/12/2025 at 07:35, 11 months 18 days ago Crossject Reappoints Key Members to Executive Board Executive Board Crossject ZEPIZURE® Reappointment Needle-free Technology
BRIEF published on 02/12/2025 at 07:35, 11 months 18 days ago Crossject renouvelle le mandat de membres clés de son conseil d'administration Conseil Exécutif Crossject ZEPIZURE® Renouvellement De Nomination Technologie Sans Aiguille
PRESS RELEASE published on 02/12/2025 at 07:30, 11 months 18 days ago Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board Crossject reappoints Patrick Alexandre and Isabelle Liebschutz to its Executive Board, focusing on final stages of ZEPIZURE registration with the FDA Executive Board Crossject Patrick Alexandre Isabelle Liebschutz ZEPIZURE Registration
PRESS RELEASE published on 02/12/2025 at 07:30, 11 months 18 days ago Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré Crossject renouvelle Patrick Alexandre et Isabelle Liebschutz au sein d'un nouveau Directoire resserré pour se concentrer sur l'enregistrement du ZEPIZURE® auprès de la FDA et la commercialisation aux Etats-Unis FDA Renouvellement Crossject ZEPIZURE® Directoire
BRIEF published on 02/06/2025 at 07:35, 11 months 24 days ago Modification des Obligations Convertibles par Crossject Financement Obligations Convertibles Crossject ZEPIZURE Heights Capital
BRIEF published on 02/06/2025 at 07:35, 11 months 24 days ago Modification of Convertible Bonds by Crossject Convertible Bonds Funding Crossject ZEPIZURE Heights Capital
Published on 01/30/2026 at 08:35, 4 hours 9 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 4 hours 44 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 10 hours 29 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 12 hours 44 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 13 hours 44 minutes ago PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/30/2026 at 12:00, 44 minutes ago HSBC UK and Sage simplify tax reporting for small businesses ahead of Making Tax Digital
Published on 01/30/2026 at 11:54, 50 minutes ago EQS-Adhoc: YOC AG: PRELIMINARY FIGURES FOR THE 2025 FINANCIAL YEAR
Published on 01/30/2026 at 10:30, 2 hours 14 minutes ago ASTA ENERGY SOLUTIONS AG SUCCESSFULLY COMPLETES IPO
Published on 01/30/2026 at 10:08, 2 hours 36 minutes ago Désastreux pour le climat et l'économie: auto-suisse critique sévèrement le refus d'assouplir les prescriptions CO2
Published on 01/30/2026 at 10:00, 2 hours 44 minutes ago Appointment of Managing Director of Tradegate BSX
Published on 01/30/2026 at 08:30, 4 hours 14 minutes ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
Published on 01/30/2026 at 08:00, 4 hours 44 minutes ago AMA : Chiffre d'affaires du 4ème trimestre et de l'année 2025
Published on 01/29/2026 at 18:30, 18 hours 14 minutes ago ALPOU - Groupe POULAILLON chiffre d'affaires trimestriel T1 2025-2026 et Focus sur les activités